Election Impact: Key Senate Committees
Following the Nov. 8 elections, the power of the incumbency prevailed, and there were few election-related changes to key committee assignments in the Senate Finance Committee, which oversees Medicare, health and tax policy, and in the Senate Health, Education, Labor and Pensions (HELP) panel, which oversees FDA and other health policy issues. Some members may choose to switch assignments once the next Congress convenes in January 2017, however.
You may also be interested in...
With an all-Republican House, Senate and administration lined up to lead the government following the 2016 elections, the path is clear for passage of a set of FDA reforms to ease device approvals embedded in a combined House 'Cures' and Senate medical innovation package. It could even happen over the upcoming lame-duck session, before the new administration and Congress take over. But controversy around price-gouging by drug firms still could stymie quick Cures bill passage, an industry attorney predicts. Meanwhile, medtech industry groups plan to seize on the Trump victory as a means to achieve permanent device tax repeal.
Major Chinese biopharma contract services group WuXi Biologics' share price plummeted after it said external factors would contribute to it missing original revenue targets this year in multiple areas.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.